Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study

Abstract Background Second line anti-tuberculosis drugs are substantially complex, long term, more costly, and more toxic than first line anti-tuberculosis drugs. In Ethiopia, evidence on the incidence and predictors of adverse drug events has been limited. Thus, this study aimed at assessing incide...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Mehari Woldemariam Merid, Lemma Derseh Gezie, Getahun Molla Kassa, Atalay Goshu Muluneh, Temesgen Yihunie Akalu, Melaku Kindie Yenit
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2019-03-01
Sarja:	BMC Infectious Diseases
Aiheet:	Adverse drug event Drug resistant tuberculosis Second-line anti-tuberculosis drugs
Linkit:	http://link.springer.com/article/10.1186/s12879-019-3919-1
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!